Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Cancer (NSCLC) With Brain Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07505173
What this trial is testing

Hippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung Cancer

Who this might be right for
Naive Advanced Non-small Cell Lung Cancer With EGFR-sensitive Mutations (EGFR Exon 19 Deletion and Exon 21 L858R Mutation) and Symptomatic Brain Metastases
Tianjin Medical University Cancer Institute and Hospital 74
Large-scale testing (Phase 3)Study completedNCT00377156
What this trial is testing

Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Who this might be right for
Breast CancerCognitive/Functional EffectsLung Cancer+2 more
Alliance for Clinical Trials in Oncology 213
Testing effectiveness (Phase 2)Study completedNCT05146219
What this trial is testing

Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation

Who this might be right for
NSCLCEGFR Activating MutationBrain Metastases+1 more
TYK Medicines, Inc 29
Testing effectiveness (Phase 2)Ended earlyNCT01497665
What this trial is testing

GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC) With Brain Metastases
Angiochem Inc 16
Not applicableUnknownNCT04778800
What this trial is testing

A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)

Who this might be right for
NSCLCBrain MetastasesLeptomeningeal Metastasis
Henan Cancer Hospital 60
Large-scale testing (Phase 3)Study completedNCT04768075
What this trial is testing

Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Guangdong Association of Clinical Trials 60
Large-scale testing (Phase 3)Looking for participantsNCT05800223
What this trial is testing

Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Shanghai Cancer Hospital, China 300
Testing effectiveness (Phase 2)Looking for participantsNCT06248606
What this trial is testing

Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases

Who this might be right for
Non Small Cell Lung CancerNSCLCKRAS G12C
Ryan Gentzler, MD 30
Testing effectiveness (Phase 2)UnknownNCT05477615
What this trial is testing

Lazertinib/Pemetrexed/Carboplatin After Osimertinib Failure in NSCLC With Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer
Jin Hyoung Kang 28
Testing effectiveness (Phase 2)WithdrawnNCT01679743
What this trial is testing

GRN1005 for Brain Metastases From Breast or Lung Cancer

Who this might be right for
Breast CancerLung NeoplasmsBreast Neoplasms+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT02073968
What this trial is testing

PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer

Who this might be right for
Metastatic Malignant Neoplasm in the BrainRecurrent Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+4 more
Albert Einstein College of Medicine 35
Testing effectiveness (Phase 2)Looking for participantsNCT06702826
What this trial is testing

Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases

Who this might be right for
Non Small Cell Lung CancerBrain MetastasesStereotactic Radiation+1 more
Rongrong Zhou 20
Not applicableStudy completedNCT00071344
What this trial is testing

Analysis of Brain Metastasis in Patients With Lung Cancer

Who this might be right for
Carcinoma, Non-Small -Cell Lung
National Institute of Neurological Disorders and Stroke (NINDS) 78
Testing effectiveness (Phase 2)Study completedNCT00227019
What this trial is testing

Phase 2 Trial of Bevacizumab in Combination With Pemetrexed

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Lung CancerNeoplasm Metastasis
Heather Wakelee 16
Early research (Phase 1)Ended earlyNCT00937482
What this trial is testing

Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Male Breast CancerStage IV Breast CancerStage IV Melanoma+7 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)WithdrawnNCT01913067
What this trial is testing

Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC

Who this might be right for
Brain MetastasisBreast CancerNon Small Cell Lung Cancer
Jules Bordet Institute
Testing effectiveness (Phase 2)UnknownNCT03356600
What this trial is testing

Apatinib Plus Radiotherapy for Patients With Brain Metastases From Non-small-cell Lung Cancer

Who this might be right for
Brain Metastases
Shanxi Province Cancer Hospital 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT02696993
What this trial is testing

Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer

Who this might be right for
Metastatic Malignant Neoplasm in the BrainStage IV Non-Small Cell Lung Cancer AJCC v7
M.D. Anderson Cancer Center 80
Testing effectiveness (Phase 2)UnknownNCT04193007
What this trial is testing

The Role of Brain Radiotherapy in Patients With Asymptomatic Brain Metastasis in the Era of Targeted Therapy for NSCLC

Who this might be right for
Non Small Cell Lung CancerBrain Metastases
Second Affiliated Hospital of Nanchang University 100
Not applicableLooking for participantsNCT07008287
What this trial is testing

Real-world Study of Taletrectinib for Advanced ROS1+ NSCLC With Brain Metastases

Who this might be right for
Non-Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 100
Next Page